Skip to main content
. 2019 Mar 26;7:e6665. doi: 10.7717/peerj.6665

Table 2. Pharmacokinetic parameters of quercetin (Qr), isoquercitrin (IQ), and quercetin-3-O-β-D-glucuronide (QG) after oral administration of 50 mg/kg Qr, IQ, and QG separately in rats.

(Mean ± SD, n = 5).

Pharmacokinetic parameters Qr group IQ group QG group
Qr QG IQ Qr QG QG Qr
AUC0−t (mg/L*min) 2,590.5 ± 987.9 1,150.0 ± 454.2 17.2 ± 7.3 2,212.7 ± 914.1 669.3 ± 188.3 962.7 ± 602.3 3,505.7 ± 1,565.0
MRT0−t (min) 383.3 ± 24.3 315.9 ± 134.7 40.6 ± 7.2 422.6 ± 148.6 355.9 ± 94.6 437.8 ± 36.3 491.1 ± 22.6
t1/2z (min) 437.3 ± 54.3 545.8 ± 436.6 42.6 ± 27.9 378.4 ± 338.8 523.5 ± 190.4 376.4 ± 95.2 365.4 ± 152.1
Tmax (min) 54.0 ± 25.1 42.0 ± 16.4 27.0 ± 6.7 42.0 ± 16.4 30.0 ± 0.0 222.0 ± 119.2 360 ± 120
CL (L/min/kg) 0.02 ± 0.008 0.043 ± 0.029 2.91 ± 1.29 0.024 ± 0.011 0.07 ± 0.02 0.071 ± 0.057 0.014 ± 0.014
Cmax (ug/mL) 7.47 ± 2.63 6.46 ± 2.94 0.35 ± 0.11 6.60 ± 2.67 3.91 ± 1.34 2.04 ± 0.85 5.17 ± 1.85

Note:

AUC, the area under concentration-time curve; MRT, mean residence time; t1/2z, half-life; Cmax, maximum plasma concentration; and Tmax, time; CL, clearance rate.